Definitive Contract 75N95026C00006
- Not listed
- This is a definitive contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to the University of Pittsburgh to establish and operate the NEUROBIOBANK Brain and Tissue Repository. The contract is valued at $18,517,576.37 and has an ultimate completion date of October 31, 2025. The purpose of the contract is to administratively de-obligate unexpended and expiring fiscal year 2020 funding in preparation for the September 30, 2025...
- The National Institute on Drug Abuse (NIDA) has awarded a definitive cost-plus-no-fee contract valued at $30.3M to the University of Maryland, Baltimore to establish and operate the NIH NeuroBioBank Brain and Tissue Repository (NBB), a collection site that will acquire, process, store, curate, preserve, and distribute central nervous system (CNS) and related tissue samples for neurological, psychiatric, and neurodevelopmental disorder research. The contract, which carries no set-aside...
- The National Institute on Drug Abuse (NIDA) awarded a definitive cost-no-fee contract to the University of Miami's Office of Research Administration in the School of Medicine to establish and operate the NIH Neurobiobank Brain and Tissue Repository (NBB) collection site in South Miami, Florida. Under this $26.6 million contract through October 31, 2030, the University of Miami will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system (CNS) and...
- The National Institute on Drug Abuse (NIDA) awarded a $18.5M cost-plus-no-fee definitive contract to the Icahn School of Medicine at Mount Sinai to establish and operate the NIH NeuroBank Brain and Tissue Repository, a collection site for acquiring, processing, storing, curating, and distributing central nervous system and related tissue samples for neuroscience research. The contract, which commenced November 1, 2025, and runs through October 31, 2030, was awarded without set-aside...
- This federal contract was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to the University of Miami to establish a collection site (the NIH Brain and Tissue Repository) that will actively acquire, receive, store, curate, preserve, and distribute central nervous system and related biological specimens for research on neurological, psychiatric, and neurodevelopmental disorders. The $25,542,514.53 contract is for a definitive, cost-no-fee...
- The National Institute on Drug Abuse awarded a $13.1M cost-plus-no-fee definitive contract to The University of Iowa to establish and operate the NIH NeuroBank Brain and Tissue Repository (NBB), a collection site for acquiring, processing, storing, curating, preserving, and distributing central nervous system tissues and related materials for neurological, psychiatric, and neurodevelopmental disorder research. The contract, which commenced November 1, 2025 and extends through October 31, 2030,...
- This federal contract was awarded by the National Institutes of Health (NIH) to the University of Maryland, Baltimore (UMB) to administer the NIH NeuroBioBank and Tissue Repository. The purpose is to increase the availability of human brain tissue samples for research on neurological, psychiatric, and neurodevelopmental disorders. The contract has a ceiling value of $23,683,813.78 and was awarded on a cost-no-fee basis with an ultimate completion date of October 31, 2025. It is not a set-aside...
- The National Institute on Drug Abuse awarded a definitive cost-no-fee contract valued at approximately $34.5 million to The McLean Hospital Corporation to establish and operate the NIH NeuroBank Brain and Tissue Repository collection site in Belmont, Massachusetts. Under this five-year contract extending through October 31, 2030, McLean Hospital will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system (CNS) and related tissues for neurological,...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to the Greater Los Angeles Veterans Research And Education Foundation (GLAVREF), a non-profit organization. The contract, valued at $12,774,018.84, is for the NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY and has a period of performance from September 1, 2019 to August 31, 2020, with a potential ultimate completion date of October 31, 2025. The...
- This is a $15,570,163.30 definitive contract awarded by the National Institute on Drug Abuse (part of the National Institutes of Health) to the Icahn School of Medicine at Mount Sinai (ISMMS) to establish a collection site for the NIH Brain and Tissue Repository (NBTR). The purpose is to acquire, receive, process, store, curate, preserve, and distribute central nervous system and related biological samples to support research on neurological, psychiatric, and neurodevelopmental disorders. The...
The National Institute on Drug Abuse awarded a $19.9M definitive cost-no-fee contract to the University of Pittsburgh to establish and operate the NIH NeuroRioBank Brain and Tissue Repository, a collection site that will actively acquire, process, store, curate, preserve, and distribute central nervous system and related tissues for research purposes. The contract, which runs through October 31, 2030, supports the broader NIH initiative to increase availability of post-mortem human brain tissue for neurological, psychiatric, and neurodevelopmental disorder research. Under the solicitation (75N95024R00124), the University of Pittsburgh must demonstrate capability to acquire at least 70 donors annually with potential to process up to 150 unique human donors per year, ensuring demographic diversity across race, ethnicity, and age groups, including individuals with various neurodevelopmental and neuropsychiatric disorders as well as those with no known brain disorders. The contract operates under full and open competition with no set-aside designation and requires the contractor to document and maintain inventory through the NIH NeuroRioBank Portal while participating in tissue sharing under NIH NeuroRioBank guidelines. This represents part of a larger multiple-award strategy coordinated across several NIH institutes, including the National Institute of Mental Health, National Institute of Child Health and Human Development, National Institute of Neurological Diseases and Stroke, and National Institute on Aging, to establish multiple collection sites nationwide. The University of Pittsburgh's established infrastructure for biomedical research and prior experience providing postmortem brain tissue samples position it to support this critical research initiative spanning the five-year performance period.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NIH NeuroBioBank Brain and Tissue Repository | 75N95024R00124 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 2/2 | 10/15/24, 3:08 PM | |
NIH NeuroBioBank Brain and Tissue Repository | 75N95024R00124 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Pre-Solicitation 1/2 | 9/30/24, 2:52 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 10/31/25 |